Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Chair of CGEn’s Scientific Advisory Board, Dr. Edward M. Rubin has been named a Fellow of the prestigious Royal Society of Canada (RSC) in recognition of his long-term contributions to advancing genomics internationally.
With this renewed support from the Government of Canada through the CFI, CGEn is poised to embark upon the next stage of its strategic vision, continuing to provide the leading genomic infrastructure for Canada’s research and innovation community.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.
